Evercore ISI lowered the firm’s price target on Cardlytics (CDLX) to $3 from $4 and keeps an In Line rating on the shares in the wake of a “Beat and Lower” quarter. The firm notes the company made continued progress in Q4 on campaign delivery issues and drove higher than expected pipeline wins, helping to offset anticipated spend reductions from key accounts in the restaurant and travel verticals. However, management’s Q1 outlook was muted and commentary for the remainder of FY25 suggests to Evercore a more gradual billings rebound than it had previously expected. While the firm sees some green shoots and encouraging signs of progress here, it now views the path to sustainably positive adjusted EBITDA as a bit longer.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDLX:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue